Global Bioprosthetic Valve Market Growth 2025-2031

Global Bioprosthetic Valve Market Growth 2025-2031

The global Bioprosthetic Valve market size is predicted to grow from US$ 223 million in 2025 to US$ 293 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

United States market for Bioprosthetic Valve is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bioprosthetic Valve is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bioprosthetic Valve is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bioprosthetic Valve players cover Abbott, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Medtronic Plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Bioprosthetic Valve Industry Forecast” looks at past sales and reviews total world Bioprosthetic Valve sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioprosthetic Valve sales for 2025 through 2031. With Bioprosthetic Valve sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioprosthetic Valve industry.

This Insight Report provides a comprehensive analysis of the global Bioprosthetic Valve landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioprosthetic Valve portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioprosthetic Valve market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioprosthetic Valve and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioprosthetic Valve.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioprosthetic Valve market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Tissue Aortic Valve
Tissue Mitral Valve

Segmentation by Application:
Hospitals
Ambulatory Surgery Centres

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Boston Scientific Corporation
CryoLife
Edwards Lifesciences Corporation
Medtronic Plc
LivaNova Plc
Claret Medical
Meril Life Sciences
Neovasc Inc
Abbott
Sorin

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bioprosthetic Valve market?

What factors are driving Bioprosthetic Valve market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bioprosthetic Valve market opportunities vary by end market size?

How does Bioprosthetic Valve break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.